Embed Size (px)
Citation preview
New Komen Scholars Pfizer Funds to Study Metastatic Breast Cancer
Welcome to the New Komen Scholars
In April Susan G Komen welcomed 16new leaders to the Komen Scholarsprogram bringing expertise in metastaticbreast cancer prevention disparitiespatient advocacy and more You canread more about the incoming KomenScholars here and can learn more aboutthe 60 current Komen Scholars here
Pfizerrsquos Breast Cancer A Story Half Told Initiativeto Support Metastatic Breast Cancer Research
Susan G Komen has been named asone of five leading breast cancerorganizations receiving funds fromPfizer Inc to support metastatic breastcancer (MBC) research as part of theirBreast Cancer A Story Half Toldinitiative These funds will build onKomenrsquos longtime investment in MBC
Subscribe Share Past Issues Translate
research which you can read about inour Metastatic Breast Cancer ResearchFast Facts Learn more about Komenrsquosaward from Pfizer here
A Perfect Storm Series ConcludeshellipOver the past two editions of RUN wehave been highlighting a series ofarticles in Oncology Practicecoauthored by Komens Board ofDirectors member Dr OlufunmilayoOlopade focused on racial disparities inbreast cancer treatment outcomes Thefinal two parts of the series have nowbeen published with Part 4 focusing oninterventions to close the survival gapwhile Part 5 looked at delivery systemreform and precision medicine for allPlease stay tuned to komenorg for ourupcoming summary of this thoughtshyprovoking series
Komen Leadership News and Views
Big Data Innovation and Breast CancerSusan G Komen President and CEOJudy Salerno participated in theBloomberg Government panel on BigData which took place in late April inWashington DC You can watch the fullpanel presentation here Dr Salerno
was one of several participants whospoke about the panel withHealthcareDIVEcom you can read thearticle here
Diligence Persistence and the Power of AdvocacyDr Salerno joined hundreds of advocatesand Komen Affiliate representatives onCapitol Hill to promote Komenrsquos advocacypriorities as part of the larger KomenAdvocacy Summit which was held April13shy15 Dr Salerno wrote about herexperience in her Huffington Post blogpost which you can read here You canread more about this effort in Komenrsquospress release here
Want more Dr Salernorsquos most recentHuffington Post blog post whichfocused on family health history andbreast cancer can be found here
Funding Opportunity Announcement
2016shy2017 Komen Research Funding Deadline is July 14
Komen continues its research investment in our future scientists Earlyshycareerbreast cancer researchers anywhere in the world are invited to apply by July 14at 1 pm ESTNew this year the Graduate Training in Disparities Research (GTDR) grants willonly be a oneshystep process and will not require a Letter of Intent The Request forApplications (RFA) will be released later this summer
For more information please visit wwwkomenorgRFA
Komen Highlights
Making Every Day Count in ResearchWe recently updated our ldquoDay in theLiferdquo oneshypage documents one ofseveral pieces that highlight how ourinvestments are working to end breastcancer forever Be sure to check out theResearch Programs document to learnmore about the ways that we all have animpact on breast cancer research Interested in Community Health Youcan find a similar document about ourCommunity Health investments here
What You Need to Know About Genetic TestingThe study of genetics and breast cancerhas evolved rapidly over the pastdecade With research advancementswhat used to be a simple test looking atonly one or two genes has quicklygrown into tests of large panels ofgenes Read more about the currentstate of genetic testing and findadditional resources on this topic in ourlatest Komen Perspectives article
Upcoming ConferencesSusan G Komen partners with other breast cancer organizations professionalsocieties and academic institutions to support a number of patientshyfocused meetingsand scientific conferences each year Below is a list of Komenshysponsored meetings ()as well as other conferences that may be of interest
American Society of Clinical Oncology (ASCO) Annual Meeting (Chicago IL) ndashJune 3shy7Young Survival Coalition (YSC) Regional Symposium (Minneapolis MN) ndash June424th Biennial Congress of the European Association for Cancer Research(EACR24) (Manchester UK) ndash July 9shy1230th Conference of the International Association for Breast Cancer Research(IABCR) (Portland OR) ndash Aug 4shy7Lynn Sage Breast Cancer Symposium (Chicago IL) ndash Sept 22shy259th AACR Conference on the Science of Cancer Health Disparities inRacialEthnic Minorities and the Medically Underserved (Ft Lauderdale FL) ndashSept 25shy281st International Invasive Lobular Cancer (ILC) Symposium (Pittsburgh PA) ndashSept 29shy3010th Annual FORCEs Against Hereditary Cancer Conference (Orlando FL) ndashOct 6shy8
If you will be presenting your Komenshyfunded research at any of these conferences andif you need the Komen logo to include on your poster or presentation please be sure tolet your Science Manager know or email us at researchprogramskomenorg
Komen Kudos
Komen Scholar Dr Jennifer Pietenpol (pictured) andPromise Grant recipient Dr Edith Mitchell were namedto the NCI Blue Ribbon Panel for the CancerMoonshot
SAB member Dr Myles Brown was elected to theNational Academy of Sciences
Komen Scholar Dr Joe Gray was elected to the 2016Class of Fellows of the American Association forCancer Research (AACR) Academy
New Komen Scholar Dr Yibin Kang is the Presidentshyelect of the Metastatic Research Society (MRS) hewill serve as President of the Society in 2017shy2018
Finally in the February edition of RUN we mentioned that Komen Scholar Dr MaryshyClaire King had been selected to receive the National Medal of Science in recognitionof her more than 40 years of breast cancer research including the discovery of theBRCA1 gene We are thrilled to report that Dr King received her medal from President
Obama during a ceremony at the White House on May 19th You can read more aboutthis event here
Komen Research in the News
Health News mdash A Komenshyfunded study developed the first technique for viewingcells and tissues in three dimensions under the skin This work could improvediagnosis and treatment for some forms of cancer and blindnessScience Newsline mdash Working with human breast cancer cells a team of Komenshyfunded scientists has successfully turned off a ldquomisbehaving proteinrdquo that fuelsthe growth of tripleshynegative breast cancerScience Newsline mdash A Komenshyfunded study has identified gene alterations thatmay explain why TNBC is resistant to most existing treatments and suggeststhat a targeted therapy currently in clinical development may prove beneficialTech Times mdash Komenshyfunded researchers have discovered a biomarker thatexists in the normal breast tissue of women which can be used to determinewhether they are at high risk of developing breast cancer later in lifeHealth Canal mdash A Komenshyfunded study has found that women with breastcancer who know the characteristics of their tumor are more likely to receive thetreatment recommended for their type of cancer
Medical News Today mdash A Komenshyfunded study has identified a new mechanismwhere breast cancer growth is helped by myeloidshyderived suppressor cells(MDSCs) an immune cell that suppresses the bodyrsquos response against tumorsPM 360 mdash According to a Komenshyfunded study the combination of a 21shygenerecurrence score and quantitative estrogen receptor expression may helpclinicians identify patients with estrogen receptorndashpositive breast cancer who aremost likely to benefit from hormonal therapy extended beyond the customary fiveyears Health Canal mdash Funded by Komen a multishyinstitutional team of scientistscompleted the first largeshyscale ldquoproteogenomicrdquo study of breast cancer linkingDNA mutations to protein signaling and helping pinpoint the genes that drivecancer
Copyright copy 2016 Susan G Komenreg All rights reserved
unsubscribe from this list update subscription preferences
research which you can read about inour Metastatic Breast Cancer ResearchFast Facts Learn more about Komenrsquosaward from Pfizer here
A Perfect Storm Series ConcludeshellipOver the past two editions of RUN wehave been highlighting a series ofarticles in Oncology Practicecoauthored by Komens Board ofDirectors member Dr OlufunmilayoOlopade focused on racial disparities inbreast cancer treatment outcomes Thefinal two parts of the series have nowbeen published with Part 4 focusing oninterventions to close the survival gapwhile Part 5 looked at delivery systemreform and precision medicine for allPlease stay tuned to komenorg for ourupcoming summary of this thoughtshyprovoking series
Komen Leadership News and Views
Big Data Innovation and Breast CancerSusan G Komen President and CEOJudy Salerno participated in theBloomberg Government panel on BigData which took place in late April inWashington DC You can watch the fullpanel presentation here Dr Salerno
was one of several participants whospoke about the panel withHealthcareDIVEcom you can read thearticle here
Diligence Persistence and the Power of AdvocacyDr Salerno joined hundreds of advocatesand Komen Affiliate representatives onCapitol Hill to promote Komenrsquos advocacypriorities as part of the larger KomenAdvocacy Summit which was held April13shy15 Dr Salerno wrote about herexperience in her Huffington Post blogpost which you can read here You canread more about this effort in Komenrsquospress release here
Want more Dr Salernorsquos most recentHuffington Post blog post whichfocused on family health history andbreast cancer can be found here
Funding Opportunity Announcement
2016shy2017 Komen Research Funding Deadline is July 14
Komen continues its research investment in our future scientists Earlyshycareerbreast cancer researchers anywhere in the world are invited to apply by July 14at 1 pm ESTNew this year the Graduate Training in Disparities Research (GTDR) grants willonly be a oneshystep process and will not require a Letter of Intent The Request forApplications (RFA) will be released later this summer
For more information please visit wwwkomenorgRFA
Komen Highlights
Making Every Day Count in ResearchWe recently updated our ldquoDay in theLiferdquo oneshypage documents one ofseveral pieces that highlight how ourinvestments are working to end breastcancer forever Be sure to check out theResearch Programs document to learnmore about the ways that we all have animpact on breast cancer research Interested in Community Health Youcan find a similar document about ourCommunity Health investments here
What You Need to Know About Genetic TestingThe study of genetics and breast cancerhas evolved rapidly over the pastdecade With research advancementswhat used to be a simple test looking atonly one or two genes has quicklygrown into tests of large panels ofgenes Read more about the currentstate of genetic testing and findadditional resources on this topic in ourlatest Komen Perspectives article
Upcoming ConferencesSusan G Komen partners with other breast cancer organizations professionalsocieties and academic institutions to support a number of patientshyfocused meetingsand scientific conferences each year Below is a list of Komenshysponsored meetings ()as well as other conferences that may be of interest
American Society of Clinical Oncology (ASCO) Annual Meeting (Chicago IL) ndashJune 3shy7Young Survival Coalition (YSC) Regional Symposium (Minneapolis MN) ndash June424th Biennial Congress of the European Association for Cancer Research(EACR24) (Manchester UK) ndash July 9shy1230th Conference of the International Association for Breast Cancer Research(IABCR) (Portland OR) ndash Aug 4shy7Lynn Sage Breast Cancer Symposium (Chicago IL) ndash Sept 22shy259th AACR Conference on the Science of Cancer Health Disparities inRacialEthnic Minorities and the Medically Underserved (Ft Lauderdale FL) ndashSept 25shy281st International Invasive Lobular Cancer (ILC) Symposium (Pittsburgh PA) ndashSept 29shy3010th Annual FORCEs Against Hereditary Cancer Conference (Orlando FL) ndashOct 6shy8
If you will be presenting your Komenshyfunded research at any of these conferences andif you need the Komen logo to include on your poster or presentation please be sure tolet your Science Manager know or email us at researchprogramskomenorg
Komen Kudos
Komen Scholar Dr Jennifer Pietenpol (pictured) andPromise Grant recipient Dr Edith Mitchell were namedto the NCI Blue Ribbon Panel for the CancerMoonshot
SAB member Dr Myles Brown was elected to theNational Academy of Sciences
Komen Scholar Dr Joe Gray was elected to the 2016Class of Fellows of the American Association forCancer Research (AACR) Academy
New Komen Scholar Dr Yibin Kang is the Presidentshyelect of the Metastatic Research Society (MRS) hewill serve as President of the Society in 2017shy2018
Finally in the February edition of RUN we mentioned that Komen Scholar Dr MaryshyClaire King had been selected to receive the National Medal of Science in recognitionof her more than 40 years of breast cancer research including the discovery of theBRCA1 gene We are thrilled to report that Dr King received her medal from President
Obama during a ceremony at the White House on May 19th You can read more aboutthis event here
Komen Research in the News
Health News mdash A Komenshyfunded study developed the first technique for viewingcells and tissues in three dimensions under the skin This work could improvediagnosis and treatment for some forms of cancer and blindnessScience Newsline mdash Working with human breast cancer cells a team of Komenshyfunded scientists has successfully turned off a ldquomisbehaving proteinrdquo that fuelsthe growth of tripleshynegative breast cancerScience Newsline mdash A Komenshyfunded study has identified gene alterations thatmay explain why TNBC is resistant to most existing treatments and suggeststhat a targeted therapy currently in clinical development may prove beneficialTech Times mdash Komenshyfunded researchers have discovered a biomarker thatexists in the normal breast tissue of women which can be used to determinewhether they are at high risk of developing breast cancer later in lifeHealth Canal mdash A Komenshyfunded study has found that women with breastcancer who know the characteristics of their tumor are more likely to receive thetreatment recommended for their type of cancer
Medical News Today mdash A Komenshyfunded study has identified a new mechanismwhere breast cancer growth is helped by myeloidshyderived suppressor cells(MDSCs) an immune cell that suppresses the bodyrsquos response against tumorsPM 360 mdash According to a Komenshyfunded study the combination of a 21shygenerecurrence score and quantitative estrogen receptor expression may helpclinicians identify patients with estrogen receptorndashpositive breast cancer who aremost likely to benefit from hormonal therapy extended beyond the customary fiveyears Health Canal mdash Funded by Komen a multishyinstitutional team of scientistscompleted the first largeshyscale ldquoproteogenomicrdquo study of breast cancer linkingDNA mutations to protein signaling and helping pinpoint the genes that drivecancer
Copyright copy 2016 Susan G Komenreg All rights reserved
unsubscribe from this list update subscription preferences
was one of several participants whospoke about the panel withHealthcareDIVEcom you can read thearticle here
Diligence Persistence and the Power of AdvocacyDr Salerno joined hundreds of advocatesand Komen Affiliate representatives onCapitol Hill to promote Komenrsquos advocacypriorities as part of the larger KomenAdvocacy Summit which was held April13shy15 Dr Salerno wrote about herexperience in her Huffington Post blogpost which you can read here You canread more about this effort in Komenrsquospress release here
Want more Dr Salernorsquos most recentHuffington Post blog post whichfocused on family health history andbreast cancer can be found here
Funding Opportunity Announcement
2016shy2017 Komen Research Funding Deadline is July 14
Komen continues its research investment in our future scientists Earlyshycareerbreast cancer researchers anywhere in the world are invited to apply by July 14at 1 pm ESTNew this year the Graduate Training in Disparities Research (GTDR) grants willonly be a oneshystep process and will not require a Letter of Intent The Request forApplications (RFA) will be released later this summer
For more information please visit wwwkomenorgRFA
Komen Highlights
Making Every Day Count in ResearchWe recently updated our ldquoDay in theLiferdquo oneshypage documents one ofseveral pieces that highlight how ourinvestments are working to end breastcancer forever Be sure to check out theResearch Programs document to learnmore about the ways that we all have animpact on breast cancer research Interested in Community Health Youcan find a similar document about ourCommunity Health investments here
What You Need to Know About Genetic TestingThe study of genetics and breast cancerhas evolved rapidly over the pastdecade With research advancementswhat used to be a simple test looking atonly one or two genes has quicklygrown into tests of large panels ofgenes Read more about the currentstate of genetic testing and findadditional resources on this topic in ourlatest Komen Perspectives article
Upcoming ConferencesSusan G Komen partners with other breast cancer organizations professionalsocieties and academic institutions to support a number of patientshyfocused meetingsand scientific conferences each year Below is a list of Komenshysponsored meetings ()as well as other conferences that may be of interest
American Society of Clinical Oncology (ASCO) Annual Meeting (Chicago IL) ndashJune 3shy7Young Survival Coalition (YSC) Regional Symposium (Minneapolis MN) ndash June424th Biennial Congress of the European Association for Cancer Research(EACR24) (Manchester UK) ndash July 9shy1230th Conference of the International Association for Breast Cancer Research(IABCR) (Portland OR) ndash Aug 4shy7Lynn Sage Breast Cancer Symposium (Chicago IL) ndash Sept 22shy259th AACR Conference on the Science of Cancer Health Disparities inRacialEthnic Minorities and the Medically Underserved (Ft Lauderdale FL) ndashSept 25shy281st International Invasive Lobular Cancer (ILC) Symposium (Pittsburgh PA) ndashSept 29shy3010th Annual FORCEs Against Hereditary Cancer Conference (Orlando FL) ndashOct 6shy8
If you will be presenting your Komenshyfunded research at any of these conferences andif you need the Komen logo to include on your poster or presentation please be sure tolet your Science Manager know or email us at researchprogramskomenorg
Komen Kudos
Komen Scholar Dr Jennifer Pietenpol (pictured) andPromise Grant recipient Dr Edith Mitchell were namedto the NCI Blue Ribbon Panel for the CancerMoonshot
SAB member Dr Myles Brown was elected to theNational Academy of Sciences
Komen Scholar Dr Joe Gray was elected to the 2016Class of Fellows of the American Association forCancer Research (AACR) Academy
New Komen Scholar Dr Yibin Kang is the Presidentshyelect of the Metastatic Research Society (MRS) hewill serve as President of the Society in 2017shy2018
Finally in the February edition of RUN we mentioned that Komen Scholar Dr MaryshyClaire King had been selected to receive the National Medal of Science in recognitionof her more than 40 years of breast cancer research including the discovery of theBRCA1 gene We are thrilled to report that Dr King received her medal from President
Obama during a ceremony at the White House on May 19th You can read more aboutthis event here
Komen Research in the News
Health News mdash A Komenshyfunded study developed the first technique for viewingcells and tissues in three dimensions under the skin This work could improvediagnosis and treatment for some forms of cancer and blindnessScience Newsline mdash Working with human breast cancer cells a team of Komenshyfunded scientists has successfully turned off a ldquomisbehaving proteinrdquo that fuelsthe growth of tripleshynegative breast cancerScience Newsline mdash A Komenshyfunded study has identified gene alterations thatmay explain why TNBC is resistant to most existing treatments and suggeststhat a targeted therapy currently in clinical development may prove beneficialTech Times mdash Komenshyfunded researchers have discovered a biomarker thatexists in the normal breast tissue of women which can be used to determinewhether they are at high risk of developing breast cancer later in lifeHealth Canal mdash A Komenshyfunded study has found that women with breastcancer who know the characteristics of their tumor are more likely to receive thetreatment recommended for their type of cancer
Medical News Today mdash A Komenshyfunded study has identified a new mechanismwhere breast cancer growth is helped by myeloidshyderived suppressor cells(MDSCs) an immune cell that suppresses the bodyrsquos response against tumorsPM 360 mdash According to a Komenshyfunded study the combination of a 21shygenerecurrence score and quantitative estrogen receptor expression may helpclinicians identify patients with estrogen receptorndashpositive breast cancer who aremost likely to benefit from hormonal therapy extended beyond the customary fiveyears Health Canal mdash Funded by Komen a multishyinstitutional team of scientistscompleted the first largeshyscale ldquoproteogenomicrdquo study of breast cancer linkingDNA mutations to protein signaling and helping pinpoint the genes that drivecancer
Copyright copy 2016 Susan G Komenreg All rights reserved
unsubscribe from this list update subscription preferences
For more information please visit wwwkomenorgRFA
Komen Highlights
Making Every Day Count in ResearchWe recently updated our ldquoDay in theLiferdquo oneshypage documents one ofseveral pieces that highlight how ourinvestments are working to end breastcancer forever Be sure to check out theResearch Programs document to learnmore about the ways that we all have animpact on breast cancer research Interested in Community Health Youcan find a similar document about ourCommunity Health investments here
What You Need to Know About Genetic TestingThe study of genetics and breast cancerhas evolved rapidly over the pastdecade With research advancementswhat used to be a simple test looking atonly one or two genes has quicklygrown into tests of large panels ofgenes Read more about the currentstate of genetic testing and findadditional resources on this topic in ourlatest Komen Perspectives article
Upcoming ConferencesSusan G Komen partners with other breast cancer organizations professionalsocieties and academic institutions to support a number of patientshyfocused meetingsand scientific conferences each year Below is a list of Komenshysponsored meetings ()as well as other conferences that may be of interest
American Society of Clinical Oncology (ASCO) Annual Meeting (Chicago IL) ndashJune 3shy7Young Survival Coalition (YSC) Regional Symposium (Minneapolis MN) ndash June424th Biennial Congress of the European Association for Cancer Research(EACR24) (Manchester UK) ndash July 9shy1230th Conference of the International Association for Breast Cancer Research(IABCR) (Portland OR) ndash Aug 4shy7Lynn Sage Breast Cancer Symposium (Chicago IL) ndash Sept 22shy259th AACR Conference on the Science of Cancer Health Disparities inRacialEthnic Minorities and the Medically Underserved (Ft Lauderdale FL) ndashSept 25shy281st International Invasive Lobular Cancer (ILC) Symposium (Pittsburgh PA) ndashSept 29shy3010th Annual FORCEs Against Hereditary Cancer Conference (Orlando FL) ndashOct 6shy8
If you will be presenting your Komenshyfunded research at any of these conferences andif you need the Komen logo to include on your poster or presentation please be sure tolet your Science Manager know or email us at researchprogramskomenorg
Komen Kudos
Komen Scholar Dr Jennifer Pietenpol (pictured) andPromise Grant recipient Dr Edith Mitchell were namedto the NCI Blue Ribbon Panel for the CancerMoonshot
SAB member Dr Myles Brown was elected to theNational Academy of Sciences
Komen Scholar Dr Joe Gray was elected to the 2016Class of Fellows of the American Association forCancer Research (AACR) Academy
New Komen Scholar Dr Yibin Kang is the Presidentshyelect of the Metastatic Research Society (MRS) hewill serve as President of the Society in 2017shy2018
Finally in the February edition of RUN we mentioned that Komen Scholar Dr MaryshyClaire King had been selected to receive the National Medal of Science in recognitionof her more than 40 years of breast cancer research including the discovery of theBRCA1 gene We are thrilled to report that Dr King received her medal from President
Obama during a ceremony at the White House on May 19th You can read more aboutthis event here
Komen Research in the News
Health News mdash A Komenshyfunded study developed the first technique for viewingcells and tissues in three dimensions under the skin This work could improvediagnosis and treatment for some forms of cancer and blindnessScience Newsline mdash Working with human breast cancer cells a team of Komenshyfunded scientists has successfully turned off a ldquomisbehaving proteinrdquo that fuelsthe growth of tripleshynegative breast cancerScience Newsline mdash A Komenshyfunded study has identified gene alterations thatmay explain why TNBC is resistant to most existing treatments and suggeststhat a targeted therapy currently in clinical development may prove beneficialTech Times mdash Komenshyfunded researchers have discovered a biomarker thatexists in the normal breast tissue of women which can be used to determinewhether they are at high risk of developing breast cancer later in lifeHealth Canal mdash A Komenshyfunded study has found that women with breastcancer who know the characteristics of their tumor are more likely to receive thetreatment recommended for their type of cancer
Medical News Today mdash A Komenshyfunded study has identified a new mechanismwhere breast cancer growth is helped by myeloidshyderived suppressor cells(MDSCs) an immune cell that suppresses the bodyrsquos response against tumorsPM 360 mdash According to a Komenshyfunded study the combination of a 21shygenerecurrence score and quantitative estrogen receptor expression may helpclinicians identify patients with estrogen receptorndashpositive breast cancer who aremost likely to benefit from hormonal therapy extended beyond the customary fiveyears Health Canal mdash Funded by Komen a multishyinstitutional team of scientistscompleted the first largeshyscale ldquoproteogenomicrdquo study of breast cancer linkingDNA mutations to protein signaling and helping pinpoint the genes that drivecancer
Copyright copy 2016 Susan G Komenreg All rights reserved
unsubscribe from this list update subscription preferences
American Society of Clinical Oncology (ASCO) Annual Meeting (Chicago IL) ndashJune 3shy7Young Survival Coalition (YSC) Regional Symposium (Minneapolis MN) ndash June424th Biennial Congress of the European Association for Cancer Research(EACR24) (Manchester UK) ndash July 9shy1230th Conference of the International Association for Breast Cancer Research(IABCR) (Portland OR) ndash Aug 4shy7Lynn Sage Breast Cancer Symposium (Chicago IL) ndash Sept 22shy259th AACR Conference on the Science of Cancer Health Disparities inRacialEthnic Minorities and the Medically Underserved (Ft Lauderdale FL) ndashSept 25shy281st International Invasive Lobular Cancer (ILC) Symposium (Pittsburgh PA) ndashSept 29shy3010th Annual FORCEs Against Hereditary Cancer Conference (Orlando FL) ndashOct 6shy8
If you will be presenting your Komenshyfunded research at any of these conferences andif you need the Komen logo to include on your poster or presentation please be sure tolet your Science Manager know or email us at researchprogramskomenorg
Komen Kudos
Komen Scholar Dr Jennifer Pietenpol (pictured) andPromise Grant recipient Dr Edith Mitchell were namedto the NCI Blue Ribbon Panel for the CancerMoonshot
SAB member Dr Myles Brown was elected to theNational Academy of Sciences
Komen Scholar Dr Joe Gray was elected to the 2016Class of Fellows of the American Association forCancer Research (AACR) Academy
New Komen Scholar Dr Yibin Kang is the Presidentshyelect of the Metastatic Research Society (MRS) hewill serve as President of the Society in 2017shy2018
Finally in the February edition of RUN we mentioned that Komen Scholar Dr MaryshyClaire King had been selected to receive the National Medal of Science in recognitionof her more than 40 years of breast cancer research including the discovery of theBRCA1 gene We are thrilled to report that Dr King received her medal from President
Obama during a ceremony at the White House on May 19th You can read more aboutthis event here
Komen Research in the News
Health News mdash A Komenshyfunded study developed the first technique for viewingcells and tissues in three dimensions under the skin This work could improvediagnosis and treatment for some forms of cancer and blindnessScience Newsline mdash Working with human breast cancer cells a team of Komenshyfunded scientists has successfully turned off a ldquomisbehaving proteinrdquo that fuelsthe growth of tripleshynegative breast cancerScience Newsline mdash A Komenshyfunded study has identified gene alterations thatmay explain why TNBC is resistant to most existing treatments and suggeststhat a targeted therapy currently in clinical development may prove beneficialTech Times mdash Komenshyfunded researchers have discovered a biomarker thatexists in the normal breast tissue of women which can be used to determinewhether they are at high risk of developing breast cancer later in lifeHealth Canal mdash A Komenshyfunded study has found that women with breastcancer who know the characteristics of their tumor are more likely to receive thetreatment recommended for their type of cancer
Medical News Today mdash A Komenshyfunded study has identified a new mechanismwhere breast cancer growth is helped by myeloidshyderived suppressor cells(MDSCs) an immune cell that suppresses the bodyrsquos response against tumorsPM 360 mdash According to a Komenshyfunded study the combination of a 21shygenerecurrence score and quantitative estrogen receptor expression may helpclinicians identify patients with estrogen receptorndashpositive breast cancer who aremost likely to benefit from hormonal therapy extended beyond the customary fiveyears Health Canal mdash Funded by Komen a multishyinstitutional team of scientistscompleted the first largeshyscale ldquoproteogenomicrdquo study of breast cancer linkingDNA mutations to protein signaling and helping pinpoint the genes that drivecancer
Copyright copy 2016 Susan G Komenreg All rights reserved
unsubscribe from this list update subscription preferences
Komen Scholar Dr Joe Gray was elected to the 2016Class of Fellows of the American Association forCancer Research (AACR) Academy
New Komen Scholar Dr Yibin Kang is the Presidentshyelect of the Metastatic Research Society (MRS) hewill serve as President of the Society in 2017shy2018
Finally in the February edition of RUN we mentioned that Komen Scholar Dr MaryshyClaire King had been selected to receive the National Medal of Science in recognitionof her more than 40 years of breast cancer research including the discovery of theBRCA1 gene We are thrilled to report that Dr King received her medal from President
Obama during a ceremony at the White House on May 19th You can read more aboutthis event here
Komen Research in the News
Health News mdash A Komenshyfunded study developed the first technique for viewingcells and tissues in three dimensions under the skin This work could improvediagnosis and treatment for some forms of cancer and blindnessScience Newsline mdash Working with human breast cancer cells a team of Komenshyfunded scientists has successfully turned off a ldquomisbehaving proteinrdquo that fuelsthe growth of tripleshynegative breast cancerScience Newsline mdash A Komenshyfunded study has identified gene alterations thatmay explain why TNBC is resistant to most existing treatments and suggeststhat a targeted therapy currently in clinical development may prove beneficialTech Times mdash Komenshyfunded researchers have discovered a biomarker thatexists in the normal breast tissue of women which can be used to determinewhether they are at high risk of developing breast cancer later in lifeHealth Canal mdash A Komenshyfunded study has found that women with breastcancer who know the characteristics of their tumor are more likely to receive thetreatment recommended for their type of cancer
Medical News Today mdash A Komenshyfunded study has identified a new mechanismwhere breast cancer growth is helped by myeloidshyderived suppressor cells(MDSCs) an immune cell that suppresses the bodyrsquos response against tumorsPM 360 mdash According to a Komenshyfunded study the combination of a 21shygenerecurrence score and quantitative estrogen receptor expression may helpclinicians identify patients with estrogen receptorndashpositive breast cancer who aremost likely to benefit from hormonal therapy extended beyond the customary fiveyears Health Canal mdash Funded by Komen a multishyinstitutional team of scientistscompleted the first largeshyscale ldquoproteogenomicrdquo study of breast cancer linkingDNA mutations to protein signaling and helping pinpoint the genes that drivecancer
Copyright copy 2016 Susan G Komenreg All rights reserved
unsubscribe from this list update subscription preferences
Medical News Today mdash A Komenshyfunded study has identified a new mechanismwhere breast cancer growth is helped by myeloidshyderived suppressor cells(MDSCs) an immune cell that suppresses the bodyrsquos response against tumorsPM 360 mdash According to a Komenshyfunded study the combination of a 21shygenerecurrence score and quantitative estrogen receptor expression may helpclinicians identify patients with estrogen receptorndashpositive breast cancer who aremost likely to benefit from hormonal therapy extended beyond the customary fiveyears Health Canal mdash Funded by Komen a multishyinstitutional team of scientistscompleted the first largeshyscale ldquoproteogenomicrdquo study of breast cancer linkingDNA mutations to protein signaling and helping pinpoint the genes that drivecancer
Copyright copy 2016 Susan G Komenreg All rights reserved
unsubscribe from this list update subscription preferences
